Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2008
10/29/2008EP1984522A2 Methods of increasing lymphatic function
10/29/2008EP1984501A2 Mcp-i binding nucleic acids
10/29/2008EP1984396A2 Inhibitors specific of presenilin-1 and their uses
10/29/2008EP1984379A2 Anti-arenaviral compounds
10/29/2008EP1984377A2 Inhibitors of tnf alpha , pde4 and b-raf, compositions thereof and methods of use therewith
10/29/2008EP1984376A2 Chemical compounds
10/29/2008EP1984374A1 Use of spiro ý imidazolidine-4, 3'-indole¨2, 2', 5' (1h) triones for treatment of conditions associated with vanilloid receptor 1
10/29/2008EP1984370A1 Imidazopyridine derivatives inhibiting protein kinase activity, method for the preparation thereof and pharmaceutical composition containing same
10/29/2008EP1984369A2 Nitroimidazole compounds
10/29/2008EP1984367A1 Trihydrochloride forms of a dihydropteridinone derivative and processes for preparation
10/29/2008EP1984366A1 3, 9-diazabicyclo ý3.3. 1¨nonane derivatives and their use as monoamine?neurotransmitter re-uptake inhibitors
10/29/2008EP1984365A1 3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/29/2008EP1984364A1 Heterobicyclic amide derivatives
10/29/2008EP1984362A1 Process for preparing intermediates to 5-ht4 receptor agonist compounds
10/29/2008EP1984361A1 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
10/29/2008EP1984360A2 Compounds and methods for modulating fx-receptors
10/29/2008EP1984359A1 Amorphous and crystalline forms of aprepitant and processes for the preparation thereof
10/29/2008EP1984357A2 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
10/29/2008EP1984353A1 Aurora kinase modulators and method of use
10/29/2008EP1984351A1 Compounds having 5-ht6 receptor affinity
10/29/2008EP1984350A1 Pyrimidine derivatives used as pi-3 kinase inhibitors
10/29/2008EP1984349A1 Piperidine derivatives as cxcr3 receptor antagonists
10/29/2008EP1984345A1 Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents
10/29/2008EP1984344A2 Multicyclic amino acid derivatives and methods of their use
10/29/2008EP1984343A2 2-substituted benzimidazoles as selective androgen receptor modulators (sarms)
10/29/2008EP1984341A1 Rimonabant monohydrate, process for the preparation thereof and pharmaceutical compositions containing same
10/29/2008EP1984340A1 Anthranilamide/2-amino-heteroarene carboxamide derivatives
10/29/2008EP1984339A1 Pyridine derivatives as sodium channel modulators
10/29/2008EP1984338A2 Pyridylphenyl compounds for inflammation and immune-related uses
10/29/2008EP1984333A1 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
10/29/2008EP1984332A2 Methods for treating hepatitis c
10/29/2008EP1984331A1 Pyrrolidine derivatives as erk inhibitors
10/29/2008EP1984330A1 Chemical compounds
10/29/2008EP1984329A2 Vitamin d analog - rak, methods and uses thereof
10/29/2008EP1984326A1 Acyclic sulfamide derivatives
10/29/2008EP1984324A1 Mandelic hydrazides
10/29/2008EP1984323A1 Viral polymerase inhibitors
10/29/2008EP1984322A1 Benzamide and heteroarene derivatives
10/29/2008EP1984317A1 Novel nutraceutical and pharmaceutical compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders
10/29/2008EP1984027A2 Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
10/29/2008EP1984026A2 Compositions and methods for treating cardiovascular, cerebrovascular and other vascular disease patients
10/29/2008EP1984024A2 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
10/29/2008EP1984010A2 Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
10/29/2008EP1984004A2 Therapy-enhancing glucan
10/29/2008EP1984003A2 Therapeutic uses of inhibitors of rtp801
10/29/2008EP1984002A1 Trialkylsilylbenzylaminocarboxyindoles, indazoles and indolines and their use in treating cetp-mediated disorders
10/29/2008EP1984001A1 Fixed-dose association of phytate and zinc
10/29/2008EP1984000A1 Novel nutraceutical compositions and pharmaceutical compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders
10/29/2008EP1983999A2 Regimens for treatment of conditions related to estrogen deficiency
10/29/2008EP1983998A2 Method of treating atrophic vaginitis
10/29/2008EP1983997A2 Crystalline forms of a farnesyl dibenzodiazepinone
10/29/2008EP1983996A2 Multi-parameter monitoring device for use with central and intravenous administration of medication
10/29/2008EP1983995A2 Novel compounds
10/29/2008EP1983994A2 Oxazole ketones as modulators of fatty acid amide hydrolase
10/29/2008EP1983993A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment
10/29/2008EP1983992A2 2-imino-benzimidazoles
10/29/2008EP1983991A2 Methods of treating alcoholism and alcohol related disorders using combination drug therapy and swellable polymers
10/29/2008EP1983990A1 A3 adenosine receptor allosteric modulators
10/29/2008EP1983989A1 Combinations of botanical extracts for promoting cardiovascular health
10/29/2008EP1983988A2 Methods and compositions for the treatment of parkinson's disease
10/29/2008EP1983987A2 Dihydrodiazepines useful as inhibitors of protein kinases
10/29/2008EP1983986A2 Piperidine derivatives as cxcr3 receptor antagonists
10/29/2008EP1983985A1 Use of naphthyridine derivatives as medicaments
10/29/2008EP1983984A2 Tuberous sclerosis treatment
10/29/2008EP1983983A1 Non-steroidal anti-inflammatory oral powder and liquid preparations for administration to animals
10/29/2008EP1983982A1 Drug combinations
10/29/2008EP1983981A1 Indazole derivatives for treatment of alzheimer's disease
10/29/2008EP1983980A2 Thiazole and thiadiazole compounds for inflammation and immune-related uses
10/29/2008EP1983979A1 Identification of compounds suitable for treating ad
10/29/2008EP1983978A2 Novel application of topical anesthetics for modulation of neurogenic tremor
10/29/2008EP1983977A2 Oxylipins from stearidonic acid and gamma-linolenic acid and methods of making and using the same
10/29/2008EP1983976A2 Composition comprising a polyunsaturated fatty acid for improving membrane composition
10/29/2008EP1983975A2 Method of treatment for muscular dystrophy
10/29/2008EP1983974A1 Use of kcnq-openers for treating or reducing the symptoms of schizophrenia
10/29/2008EP1983973A1 Oral dtpa for radionuclide chelation
10/29/2008EP1983972A2 Compounds for the treatment of metabolic disorders
10/29/2008EP1983971A2 Substituted aromatic compounds for inflammation and immune-related uses
10/29/2008EP1983967A2 Rapid release irbesartan-containing pharmaceutical composition
10/29/2008EP1983965A2 Photodynamic cosmetic procedure and healing method
10/29/2008EP1983930A2 Drug delivery system for retarding release of water soluble drugs
10/29/2008EP1983849A1 A food composition comprising amino acids
10/29/2008EP1983831A2 Phenyl and pyridyl compounds for inflammation and immune-related uses
10/29/2008EP1983828A2 Ubiquitin/proteasome inhibitors for the treatment of spinal muscular atrophy
10/29/2008EP1983823A1 Inhibitors of prolyl-hydroxylase 1 for the treatment of skeletal muscle degeneration
10/29/2008EP1951235A4 Novel crystal forms of irinotecan hydrochloride
10/29/2008EP1906916B1 Ophthalmic suspension comprising an ophthalmic drug, a poloxamine and a glycol tonicity-adjusting agent, use of said composition for the manufacture of a medicament for treating ophthalmic disorders
10/29/2008EP1891038B1 Substituted n-arylpyrrolidines as selective androgen receptor modulators
10/29/2008EP1863795B1 Substituted triazole derivatives as oxytocin antagonists
10/29/2008EP1861100B1 3,11b-cis-dihydrotetrabenazine for the treatment of a proliferative disease or an inflammation
10/29/2008EP1853280A4 Compositions and methods for treating and preventing cardiomyopathy and heart disease
10/29/2008EP1853248B1 Use of the SALTS, ADDITION COMPOUNDS AND COMPLEX COMPOUNDS OF GUANIDINOACETIC ACID
10/29/2008EP1828134B1 Piperazinyl pyridine derivatives as anti-obesity agents
10/29/2008EP1812417B1 Novel 2h-chromene derivatives as selective estrogen receptor modulators
10/29/2008EP1809602B1 Indole derivatives useful as progesterone receptor modulators
10/29/2008EP1793834B1 Indolin-2-one pyridine derivatives, preparation and therapeutic use thereof
10/29/2008EP1778686B1 Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors
10/29/2008EP1753764B1 Pyrrolopyridine derivatives
10/29/2008EP1751106B1 Piperazine derivatives of alkyl oxindoles
10/29/2008EP1751105B1 Piperazine derivatives of alkyl oxindoles
10/29/2008EP1750675B1 Stable oral pharmaceutical compositions of buprenorphine and salt thereof
1 ... 3022 3023 3024 3025 3026 3027 3028 3029 3030 3031 3032 3033 3034 3035 3036 3037 3038 3039 3040 3041 3042 ... 7860